Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Truth From Facts – Thursday, September 12, 2013

|Includes:Merck & Co Inc. (MRK)

Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics

Disclosure: I am long TSRX.

Additional disclosure: Chris DeMuth Jr is a portfolio manager at Rangeley Capital, a partnership that invests with a margin of safety by buying securities at deep discounts to their intrinsic value and unlocking that value through corporate events. In order to maximize total returns for our partners, we reserve the right to make investment decisions regarding any security without further notification except where such notification is required by law.

Stocks: MRK